Anti-NMDA receptor (anti-NMDAR) encephalitis is a treatment-responsive autoimmune encephalitis, first described in 2007.
Brain MRI and MRV were normal. CSF analysis and extensive laboratory investigations showed pleocytosis (table) . Anti-NMDAR antibodies were negative in serum, but positive in CSF, 4 confirming the diagnosis of definite anti-NMDAR encephalitis. 3 The patient was treated with IV methylprednisolone 1,000 mg (day 13, 5 days) and IV immunoglobulins 0.4 g/kg (day 16, 5 days). Thorax/abdomen CT and transvaginal ultrasound revealed 2 lesions in the pelvic area with fat tissue and calcifications, suspect for teratomas. Bilateral laparotomic ovariectomy was performed (day 19). Pathologic examination showed mature cystic teratomas, without immature components, containing nervous tissue. Hormone replacement therapy was started.
Her neurologic condition improved within a week, but the depressive mood remained. Recovery was hampered by urosepsis, treated with cefuroxime/amoxicillin. She was treated with a second course of methylprednisolone 4 weeks after the initial treatment and immunoglobulins at 8 weeks for remaining speech impairments and severe depression. This resulted in further improvement of both. After 6 weeks, the patient was transferred to a rehabilitation unit.
After 6 months, the patient returned home. She was able to perform activities of daily living independently, but needed walking aids outside due to residual ataxia and had not returned to work (yet).
Discussion
This case with cerebellar ataxia as an initial symptom highlights an unusual presentation of anti-NMDAR encephalitis. If cerebellar ataxia is present in patients with anti-NMDAR encephalitis, it is almost exclusively found in (young) children, and most frequently, it appears later in the disease in combination with other symptoms.
2 Different brainstemcerebellar symptoms have been described, such as opsoclonus-myoclonus syndrome, ocular movement abnormalities, and low cranial nerve involvement in patients with ovarian teratomas, but these symptoms have more frequently been described in whom no NMDAR antibodies could be identified. 5 Although 2 simultaneously occurring paraneoplastic neurologic syndromes, due to an ovarian teratoma, cannot be fully excluded, this is considered unlikely. The development of multiple symptoms quickly into diseases compatible with anti-NMDAR encephalitis (psychiatric symptoms and mutism), the confirmation of NMDAR antibodies by different tests, 4 and the identification of an ovarian teratoma are suitable with a diagnosis of "definite anti-NMDAR encephalitis." 3 Although it is known that anti-NMDAR IgG antibodies bind to granular cells in the cerebellum (but not to Purkinje cells), 6 it is unknown why only approximately 5% of patients show cerebellar complaints. MRI abnormalities of the cerebellum have been described in 6% of patients. 7 A small study showed progressive cerebellar atrophy by follow-up MRI in 2 of 15 patients with anti-NMDAR encephalitis. 6 In conclusion, cerebellar ataxia is unusual in adult patients and an extremely rare presenting symptom of anti-NMDAR encephalitis. This case shows that anti-NMDAR encephalitis should be considered in the differential diagnosis of cerebellar ataxia, especially in patients with previous teratomas and those developing other symptoms shortly afterward.
